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This is a short piece in response to the “Heterogeneity of European DRG systems and potentials for a common EuroDRG system”1 by Alexander Geissler, Wilm 
Quentin and Reinhard Busse from the EuroDRG team. We 
would like to thank them for taking the time to read our article 
and offer excellent suggestions to the diagnosis-related group 
(DRG) systems for further development.
We agree that there is no consensus in Europe regarding 
the best way in which to shape the DRG system.2 The main 
reasons for this are different national healthcare systems and 
the fact that DRG has been put into use at varying times and 
for various purposes. The first European country to adopt 
the DRG system was Portugal in 1984; the initial goal was 
to measure the performance of hospitals (by now, budgetary 
allocation has become the objective). Likewise in several 
other countries, the original purpose of the DRG system 
was to describe the operations of hospitals, but this was later 
based on reimbursement and budgeting. This shows that 
countries are capable of altering their DRG systems and that 
various European countries are able to move towards a more 
homogenous DRG system. An excellent example is NordDRG, 
which is already used by 3 countries.
DRGs are often first seen as a way of reimbursing hospitals, 
although they were created for a different purpose and used 
to achieve a much broader objective: to increase transparency, 
influence efficiency and support hospital management. In 
addition to reimbursement, 2 other main tasks are mentioned 
in connection with a system based on DRG. The first task 
is the assessment of treatment quality and the second is the 
assessment of service use.
Although DRGs may be quite different across countries, they 
are largely based on the same characteristics. For example, all 
types of DRG include diagnosis and procedures as clinical 
characteristics. Most types of DRG include age (except 
DBC), and the discharge type (except LKF, DBC) as the 
administrative/demographic characteristics. In addition, most 
DRGs take into consideration the LOS/same day status (except 
AP-DRG, LKF and DBC). Upon coding diagnoses, most 
countries consider the ICD-10, except Portugal and Spain, 
who use ICD-9, since AP-DRG requires this specific version 
of coding. Another peculiarity of the AP-DRG system is that 
a list of secondary diagnoses is checked in order to identify 
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cases with major complications and co-morbidities (major 
CCs), which are then collected in a specific major-CC class.2 
The scope of application of the DRG system is wider that just 
reimbursement.3 The system gives the chance to compare 
various practices of providing healthcare services and is an 
input to developing quality indicators.4 At the same time, 
every reimbursement system needs constant development, 
and so does the DRG system. The main challenge over the 
coming years is taking further steps towards healthcare 
reimbursement that would support a comprehensive patient 
approach.5 DRG plays an important role in this.
So far, the DRG system has been predominantly oriented 
towards hospital treatment, but as more and more outpatient 
services are provided, in many countries the greatest challenge 
is to apply a DRG-based reimbursement system more actively 
in order to budget outpatient surgery and treatment services 
in more detail and to plan services. The aim is to support and 
motivate medical institutions to provide more services as 
outpatient treatment, which is more convenient for patients.
Many research papers and articles were written on the 
application of, experiences with and effects of a DRG-based 
reimbursement system in the 1980s and the 1990s, but later, 
this field has been covered about much less.6 A lot of work was 
done under the EuroDRG project (Diagnosis-related groups 
in Europe: towards efficiency and quality), which resulted in 
a thorough overview of the DRG systems currently in place 
in Europe. Now, it is important to develop the subject further 
and to find opportunities to harmonise the DRG system in 
Europe. It is also important because the directive on patients’ 
rights in cross-border healthcare has been in force in the 
European Union (EU) since 2013, and the DRG system, which 
is based on similar principles, would greatly help enforce it. 
It is also important to carry out various comparative studies 
(including quality analyses) and cost-benefit analyses using 
the clinical framework of DRG.
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